Briggs Morrison, Director at Syndax Pharmaceuticals, holds 30.00K shares in Arvinas Holding Company (Ticker: ARVN), holds 34.84K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds ― shares in NextCure (Ticker: NXTC).
Briggs Morrison latest transaction was an Uninformative Buy of ―.
What was Briggs Morrison's most profitable transaction?
Briggs Morrison’s most profitable transaction was an Informative Buy of SNDX stock on October 11, 2019. The return on the trade was 155.30%.
What is Briggs Morrison's role in Syndax Pharmaceuticals?
Briggs Morrison's role in Syndax Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.